Booming Pharma Sector in India

Publication Date	August 2008
Publisher	RNCOS
Product Type	Report
Pages	100
ISBN Number	not applicable
Product Code	RCS00464

Buy this product or for assistance call +44 20 7060 7474

PDF £660.00$1098 | €739

PRINT £780.00$1297 | €873

CD-ROM £780.00$1297 | €873

FAX Order above formats by FAX

Summary

India, a US$ 8.2 Billion pharmaceutical market, represents one of the most emerging pharmaceutical markets in the world. According to the RNCOS latest report Booming Pharma Sector in India, in near future, the potential and opportunities within this market will increase by several folds. The market, presently driven by over a billion population, an expanding GDP, and rapid epidemiological transitions, is expected to be the major player in the global pharmaceutical market both in terms of its large domestic market and also as a pharmaceutical export hub. The research study contains unique market-based research and provides detailed and objective analysis on the Indian pharmaceutical market. It presents a thorough statistical and analytical overview on the Indian pharmaceutical market, and provides past, present and future data on the entire structure, composition and working of the Indian pharmaceutical market. The research extensively discusses the opportunities and challenges that are expected to arise within and from the pharmaceutical market.

Research Highlights

Between 2007-08 and 2011-12, the Indian domestic pharmaceutical market is expected to grow at a CAGR of nearly 16%.
The size of the domestic pharmaceutical market is larger than export market. However, owing to the growth of global generics market, stringent price controls in the domestic market, and better margins, the export market is growing much faster than the domestic market.
Traditional branded generics presently dominate the Indian pharmaceutical market but the future will see strong growth in the specialty branded generics and patented drug segments.
Drugs for diabetes and cardiovascular diseases are expected to see the fastest growth among all therapy areas during 2007-2011.
The retail pharmaceutical market in India is presently highly unorganized; however, a vast opportunity exists for the organized market.
Over the last few years, Cipla, Ranbaxy and GlaxoSmithKline are controlling the top three positions in the Indian pharmaceutical market.

The Report Covers

Analysis of past, current and future market trends.
Market study by segment.
Discussion about the major drivers of the pharmaceutical market.
Analysis of opportunities created by the market.
Evaluation of major challenges for the market.
Review on the government regulations.
Competitive landscape of the market.

Research Methodology Used

Information Sources

Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods

The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.

Content

1. Analyst View
2. Global Pharmaceutical Market
3. India - The Emerging Market
4. India - Macroeconomic & Healthcare Profile
- 4.1 Macroeconomic Profile
- 4.2 Population Profile
- 4.3 Healthcare Profile
5. Indian Pharmaceutical Market
- 5.1 Turnover
- 5.2 Trade
  - 5.2.1 Export
  - 5.2.2 Import
- 5.3 Bulk Drugs & Formulations
6. Domestic Pharmaceutical Market
- 6.1 What Makes the Market so Lucrative?
  - 6.1.1 Ageing Population
  - 6.1.2 Increasing Income
  - 6.1.3 Product Patent Regime
  - 6.1.4 Medical Infrastructure
  - 6.1.5 Prevalence of Lifestyle-related Diseases
- 6.2 Market Size
- 6.3 Market Segmentation
  - 6.3.1 By Drugs
    - 6.3.1.1 Traditional Branded Generics
    - 6.3.1.2 Specialty Branded Generics
    - 6.3.1.3 Generic Generics
    - 6.3.1.4 Patented Drugs
  - 6.3.2 By Therapeutics
    - 6.3.2.1 Acute Segment
    - 6.3.2.1.1 Anti-infectives
    - 6.3.2.1.2 Gastrointestinal
    - 6.3.2.1.3 Vitamins/Minerals/Nutrients
    - 6.3.2.1.4 Pain/Analgesics
    - 6.3.2.1.5 Dermatology
    - 6.3.2.1.6 Gynecology
    - 6.3.2.1.7 Respiratory
    - 6.3.2.2 Chronic Segment
    - 6.3.2.2.1 Cardiac
    - 6.3.2.2.2 Neuro/CNS
    - 6.3.2.2.3 Anti-diabetic
- 6.4 Market Structure
- 6.5 Key Players
- 6.6 Future Outlook
  - 6.6.1 Market Drivers & Restraints
  - 6.6.2 Sales (2008-09 to 2011-12)
7. Government Regulations & Market Entry
- 7.1 Industrial & Manufacturing License
- 7.2 Patent Laws
- 7.3 Research & Development
- 7.4 Pricing
- 7.5 Market Entry
8. Opportunities
- 8.1 Biogenerics
- 8.2 Rural Markets
- 8.3 Pharma Outsourcing Market
- 8.4 Bioinformatics
- 8.5 Health Insurance
- 8.6 Drug Delivery & Packaging Industry
- 8.7 Pharmaceutical Retail Chains
9. Roadblocks
- 9.1 Lack of Innovation
- 9.2 Drug Price Controls & Low Margins
- 9.3 Low Per Capita Spending on Drugs
- 9.4 Multinationals Reluctant to Invest in India
- 9.5 Counterfeit Drugs
- 9.6 Government Financing
10. Profile of Key Players
- 10.1 Ranbaxy Laboratories Limited
- 10.2 Cipla Limited
- 10.3 GlaxoSmithKline Pharmaceuticals Limited
- 10.4 Nicholas Piramal India Limited
- 10.5 Zydus Cadila
List of Figures:
- Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002, 2006, 2007 & 2012F
- Figure 3-1: Global - Top Pharmaceutical Markets (in Billion US$), 2005
- Figure 3-2: Global - Forecast for Top Pharmaceutical Markets (in Billion US$), 2015
- Figure 3-3: Global - CAGR of Top Pharmaceutical Markets (%), 2005 to 2015
- Figure 4-1: India - Nominal GDP (in Billion US$), 2001-2007
- Figure 4-2: India - Forecast for Nominal GDP (in Billion US$) 2008*-2011
- Figure 4-3: India - Consumer Price Index (%), 2001-2007
- Figure 4-4: India - Forecast for Consumer Price Index (%), 2008*-2011
- Figure 4-5: India - Total FDI (in Billion US$), 2002-03 to 2007-08
- Figure 4-6: India - FDI in Pharmaceutical Sector (in Million US$), 2003-04 to 2006-07
- Figure 4-7: India - Population (in Billion), 2003-2007
- Figure 4-8: India - Forecast for Population (in Billion), 2008*-2011
- Figure 4-9: India - Population by Gender (%), 2003-2006
- Figure 4-10: India - Population Breakup by Age (%), 2003-2007
- Figure 4-11: India - Forecast for Population Breakup by Age (%), 2008*-2011
- Figure 4-12: India - Per Head Healthcare Spending (in US$), 2001-2007
- Figure 4-13: India - Forecast for Per Head Healthcare Spending (in US$), 2008*-2011
- Figure 4-14: India - Healthcare Payments by Source (%), 2006
- Figure 4-15: India - Number of Doctors (in '000) 2005-2007E
- Figure 4-16: India - Forecast for Number of Doctors (in '000), 2008-2011
- Figure 4-17: India - Number of Nurses (in '000), 2004-2007E
- Figure 4-18: India - Forecast for Number of Nurses (in '000), 2008-2011
- Figure 4-19: India - Number of Hospital Beds (in '000), 2004-2007E
- Figure 4-20: India - Forecast for Number of Hospital Beds (in '000), 2008-2011
- Figure 4-21: India - Number of Deaths due to Leading Causes (in '000), 2005
- Figure 4-22: India - Leading Causes of Death (%), 2005
- Figure 4-23: India - Forecast for Leading Causes of Death (%), 2030
- Figure 5-1: India - Pharmaceutical Market Turnover* (in Billion INR), 2001-02 to 2007-08
- Figure 5-2: India - Breakup of Pharmaceutical Market (%), 2007-08
- Figure 5-3: India - Pharmaceutical Exports (in Billion INR), 2000-01 to 2007-08
- Figure 5-4: India - Major API Exports (in Billion INR), 2005-06
- Figure 5-5: India - Major Dosage Form Exports (in Billion INR), 2005-06
- Figure 5-6: India - Pharmaceutical Exports by Region (%), 2005-06
- Figure 5-7: India - Forecast for Pharmaceutical Exports (in Billion INR), 2008-09 to 2011-12
- Figure 5-8: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2007-08E
- Figure 5-9: India - Pharmaceutical Imports by Group (%), 2005
- Figure 5-10: India - Bulk Drugs Production* (in Billion INR), 2001-02 to 2007-08E
- Figure 5-11: India - Formulations Production* (in Billion INR), 2001-02 to 2007-08E
- Figure 6-1: India - Population of People above 65 Years (in Million), 2003-2007E
- Figure 6-2: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07E
- Figure 6-3: India - Prevalence of Lifestyle-related Diseases (%), 2005
- Figure 6-4: India - Share of Mass & Specialty Therapies in Pharmaceutical Market (%), 2004, 2006 & 2015F
- Figure 6-5: India - Domestic Pharmaceutical Market* (in Billion INR), 2001-02 to 2007-08
- Figure 6-6: India - Domestic Pharmaceutical Market by Drug Category (%), 2004
- Figure 6-7: India - Forecast for Domestic Pharmaceutical Market by Drug Category (%), 2010
- Figure 6-8: India - Traditional Branded Generics Market (in Billion US$), 2004 & 2010F
- Figure 6-9: India - Specialty Branded Generics Market (in Billion US$), 2004 & 2010F
- Figure 6-10: India - Generic Generics Market (in Billion US$), 2004 & 2010F
- Figure 6-11: India - Patented Drugs Market (in Billion US$), 2004 & 2010F
- Figure 6-12: India - Domestic Pharmaceutical Market by Therapeutic Category (%), 2007
- Figure 6-13: India - CAGR Growth of Major Therapeutic Categories (%), 2007 to 2011
- Figure 6-14: India - Anti-infectives Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-15: India - Gastrointestinal Drugs Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-16: India - Vitamins/Minerals/Nutrients Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-17: India - Pain/Analgesics Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-18: India - Dermatology Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-19: India - Gynecology Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-20: India - Number of Asthma Patients (in Million), 2005 & 2015F
- Figure 6-21: India - Respiratory Drugs Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-22: India - Number of Coronary Heart Patients (in Million), 2005 & 2015F
- Figure 6-23: India - Cardiac Drugs Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-24: India - Neuro/CNS Drugs Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-25: India - Number of Diabetes Patients (in Million), 2005 & 2015F
- Figure 6-26: India - Diabetes Market (in Billion INR), 2006, 2007 & 2011F
- Figure 6-27: India - Share of Companies in Pharmaceutical Market (%), 2006
- Figure 6-28: India - Income Distribution among Households (%), 2006-07* & 2011-12F
- Figure 6-29: India - Forecast for Prevalence of Lifestyle-related Diseases (%), 2015
- Figure 6-30: India - Forecast for Population of People above 65 Years (in Million), 2008-2011
- Figure 6-31: India - Forecast for Domestic Pharmaceutical Market* (in Billion INR), 2008-09 to 2011-12
- Figure 8-1: Global - Biogenerics Market (in Million US$), 2006 & 2011F
- Figure 8-2: India - Pharmaceutical Market by Geographical Tier (%), 2005
- Figure 8-3: India - Forecast for Pharmaceutical Market by Geographical Tier (%), 2011
- Figure 8-4: India - Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007E
- Figure 8-5: India - Pharma Outsourcing Market by Segment (%), 2006
- Figure 8-6: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2011
- Figure 8-7: India - Forecast for Pharma Outsourcing Market by Segment (%), 2011
- Figure 8-8: India - Bioinformatics Market (in Million US$), 2002-03 to 2006-07 & 2011-12F
- Figure 8-9: India - Health Insurance Market (in Billion INR), 2001-02, 2006-07 & 2011-12F
- Figure 8-10: India - Drug Packaging Market (in Billion INR), 2006-07* & 2011-12F
- Figure 9-1: India & Global - Proportion of Revenue Spent on R&D (%), 2005
- Figure 9-2: India - Spending on R&D (in Million US$), 2000-01 to 2005-06
- Figure 9-3: Global - Per Capita Drug Consumption in Top Pharmaceutical Markets (in US$), 2006
- Figure 9-4: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006
List of Tables:
- Table 2-1: Global - Market Share & Growth of Leading Therapy Classes (%), 2006
- Table 2-2: Global - Pharmaceutical Market by Region (in Billion US$), 2007
- Table 5-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
- Table 5-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
- Table 6-1: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2006
- Table 6-2: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2007
- Table 7-1: India - Launch of Patented Drugs by Product & Company
- Table 8-1: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
- Table 8-2: India - Expansion Plans of Pharmacy Retail Chains
- Table 9-1: India - Counterfeit Drugs in Domestic Pharmaceutical Market